ACE inhibitors or ARBs decrease the afterload [5], decrease the central aortic pressure, and increase the forward flow during systolic ejection so that less amount of blood regurgitates into the left atrium, thereby decreasing the mitral regurgitation. This evidence concerns the gene ACE and mitral valve insufficiency.